Aspirin lowers the risk for pancreatic cancer.
The regular use of aspirin lowers the risk for pancreatic cancer by almost 50 percent, a new study in China led by the Yale School of Public Health finds.
Researchers studied patients with newly diagnosed pancreatic cancer at 37 Shanghai hospitals from December 2006 to January 2011. The 761 patients were interviewed in person about their use of aspirin per day or week and their ages when the use started and stopped. They were matched with control patients identified from the Shanghai Residents Registry.
“This is a significant finding and helps to understand the development of pancreatic cancer,” said lead author Harvey Risch, M.D., Ph.D., professor at the Yale School of Public Health in the Department of Chronic Disease Epidemiology. “There is evidence accumulating that aspirin use slows the development of precancerous changes in the pancreas.”
Read full article: Aspirin Use Found to Lower Risk of Pancreatic Cancer
|Read Full Article: Aspirin Use Found to Lower Risk of Pancreatic Cancer|